These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4688576)

  • 1. Studies of nuclear DNA in vaginal adenosis and clear-cell adenocarcinoma.
    Lewis JL; Nordqvist SR; Richart RM
    Am J Obstet Gynecol; 1973 Mar; 115(6):737-50. PubMed ID: 4688576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DES story.
    Gunning JE
    Obstet Gynecol Surv; 1976 Nov; 31(11):827-33. PubMed ID: 980278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR; Sommers SC
    Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
    [No Abstract]   [Full Text] [Related]  

  • 7. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK; Cera PJ
    Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome.
    Fetherston WC; Meyers A; Speckhard ME
    Wis Med J; 1972 Feb; 71(2):87-93. PubMed ID: 5060564
    [No Abstract]   [Full Text] [Related]  

  • 9. Diethylstilbestrol-associated vaginal adenosis followed by clear cell adenocarcinoma.
    Sander R; Nuss RC; Rhatigan RM
    Int J Gynecol Pathol; 1986; 5(4):362-70. PubMed ID: 3643169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell adenocarcinoma of the cervix and vagina. A clinicopathologic study of 21 cases with and without a history of maternal ingestion of estrogens.
    Nordqvist SR; Fidler WJ; Woodruff JM; Lewis JL
    Cancer; 1976 Feb; 37(2):858-71. PubMed ID: 1253110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical diagnosis of vaginal adenosis.
    Stafl A; Mattingly RF; Foley DV; Fetherston WC
    Obstet Gynecol; 1974 Jan; 43(1):118-28. PubMed ID: 4808952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal bleeding and diethylstilbestrol exposure during pregnancy: relationship to genital tract clear cell adenocarcinoma and vaginal adenosis in daughters.
    Sharp GB; Cole P
    Am J Obstet Gynecol; 1990 Apr; 162(4):994-1001. PubMed ID: 2327468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Am J Obstet Gynecol; 1973 Jun; 116(4):470-84. PubMed ID: 4709483
    [No Abstract]   [Full Text] [Related]  

  • 17. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of local progesterone on stilbestrol-associated vaginal adenosis.
    Herbst AL; Robboy SJ; Macdonald GJ; Scully E
    Am J Obstet Gynecol; 1974 Mar; 118(5):607-15. PubMed ID: 4130676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.